- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07806123
OCCUPATIONAL NOISE AND CHEMICAL EXPOSURE EFFECTS ON AUDITORY AND VESTIBULAR FUNCTION
September 4, 2026 updated by: Handan Turan Dizdar, Ondokuz Mayıs University
EFFECTS OF OCCUPATIONAL NOISE AND CHEMICAL EXPOSURE ON AUDITORY AND VESTIBULAR FUNCTION IN FUEL STATION EMPLOYEES
This study aims to investigate the effects of occupational noise exposure on hearing and auditory functions among individuals working in noisy environments.
The study evaluates the relationship between occupational noise exposure and hearing-related outcomes.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Handan TURAN DİZDAR, PhD
- Phone Number: +90 505 597 06 27
- Email: handan.dizdar@omu.edu.tr
Study Contact Backup
- Name: Işılay Kaplan, Audiologist
- Phone Number: +90 555 897 03 66
- Email: isilaykplan66@gmail.com
Study Locations
-
-
-
Samsun, Turkey (Türkiye), 55139
- Ondokuz Mayıs University
-
Contact:
- Ondokuz Mayıs University
- Phone Number: +90 362 312 19 19
- Email: iletisim@omu.edu.tr
-
Sub-Investigator:
- Handan TURAN DİZDAR, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Fuel station employees aged 20-60 years and healthy individuals with similar sociodemographic characteristics who had no occupational exposure to noise or chemicals.
Description
Inclusion Criteria:
- Male participants aged 20-60 years who had been working at a fuel station for at least two years, had no hearing loss on their pre-employment audiogram, and had no history of balance loss or otologic surgery.
Exclusion Criteria:
- Individuals with middle ear pathology, a history of hearing loss, vestibular disease, or neurological or psychiatric disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Study Group
Fuel station workers exposed to occupational noise and chemical substances.
|
|
Control Group
Healthy individuals with similar sociodemographic characteristics and no exposure to occupational noise or chemical substances.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pure-Tone Audiometry Hearing Thresholds
Time Frame: Baseline
|
Hearing thresholds were assessed by pure-tone audiometry at 250, 500, 1000, 2000, and 4000 Hz in both ears and compared between the study and control groups.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acoustic Reflex Thresholds
Time Frame: Baseline
|
Ipsilateral and contralateral acoustic reflex thresholds were assessed at 500, 1000, 2000, and 4000 Hz and compared between the study and control groups.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Handan TURAN DİZDAR, PhD, Ondokuz Mayıs University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 3, 2026
Primary Completion (Estimated)
February 10, 2027
Study Completion (Estimated)
March 10, 2027
Study Registration Dates
First Submitted
September 2, 2026
First Submitted That Met QC Criteria
September 4, 2026
First Posted (Actual)
September 8, 2026
Study Record Updates
Last Update Posted (Actual)
September 8, 2026
Last Update Submitted That Met QC Criteria
September 4, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Wounds and Injuries
- Pathologic Processes
- Chemically-Induced Disorders
- Otorhinolaryngologic Diseases
- Sensation Disorders
- Ear Diseases
- Drug-Related Side Effects and Adverse Reactions
- Radiation Injuries
- Hearing Loss
- Hearing Disorders
- Hearing Loss, Sensorineural
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Ototoxicity
- Hearing Loss, Noise-Induced
Other Study ID Numbers
- 2025000065-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data will not be shared with other researchers.
Only aggregate study results will be reported in the publication.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.